Prolonged hospitalization and
antibiotic therapy are risk factors for the development of methicillin-resistant Staphylococcus aureus (MRSA)
infections in thermal
burn patients. We used a rat model to study the in vivo efficacy of
daptomycin in the treatment of
burn wound infections by S. aureus, and we evaluated the wound healing process through morphological and immunohistochemical analysis. A
copper bar heated in boiling water was applied on a paraspinal site of each rat, resulting in two full-thickness
burns. A small gauze was placed over each
burn and inoculated with 5 × 107 CFU of S. aureus ATCC 43300. The study included two uninfected control groups with and without
daptomycin treatment, an infected control group that did not receive any treatment, and two infected groups treated, respectively, with intraperitoneal
daptomycin and
teicoplanin. The main outcome measures were quantitative culture, histological evaluation of tissue repair, and immunohistochemical expression of wound healing markers:
epidermal growth factor receptor (EGFR) and
fibroblast growth factor 2 (FGF-2). The highest inhibition of
infection was achieved in the group that received
daptomycin, which reduced the bacterial load from 107 CFU/ml to about 103 CFU/g (P < 0.01). The groups treated with
daptomycin showed better overall healing with epithelialization and significantly higher
collagen scores than the other groups, and these findings were also confirmed by immunohistochemical data. In conclusion, our results support the hypothesis that
daptomycin is an important modulator of
wound repair by possibly reducing hypertrophic
burn scar formation.